| 中文名 | (D-ARG0,HYP3,D-PHE7)-BRADYKININ |
|---|---|
| 英文名 | [D-Arg0,Hyp3,D-Phe7]-Bradykinin |
| 中文别名 |
D-G0,HYP3,D-PHE7]-血管舒缓激肽
D-精氨酸0,羟脯氨酸3,D-苯丙氨酸7]缓激肽 |
| 英文别名 |
(D-ARG0,HYP3,D-PHE7)-BRADYKININ
(D-g0, Hyp 3,D-Phe7)-Bradykinin trifluoroacetate salt H-D-g-g-Pro-Hyp-Gly-Phe-Ser-D-Phe-Phe-g-OH trifluoroacetate salt D-Arg-L-Pro-L-t4Hyp-Gly-L-Phe-L-Ser-D-Phe-L-Phe-D-Arg-OH D-ARG-ARG-PRO-HYDROXY-PRO-GLY-PHE-SER-D-PHE-PHE-ARG D-g-g-Pro-t4Hyp-Gly-Phe-Ser-D-Phe-Phe-g-OH D-ARG-ARG-PRO-HYP-GLY-PHE-SER-D-PHE-PHE-ARG (D-g0,Hyp3,D-Phe7)bradikinin Bradykinin, N2-D-ginyl-3-[(4R)-4-hydroxy-L-proline]-7-D-phenylalanine D-g-L-g-L-Pro-L-t4Hyp-Gly-L-Phe-L-Ser-D-Phe-L-Phe-L-g-OH D-Arg[Hyp3,D-Phe7]-bradykinin D-Arg-Arg-Pro-t4Hyp-Gly-Phe-Ser-D-Phe-Phe-Arg-OH D-Arg-L-Arg-L-Pro-L-t4Hyp-Gly-L-Phe-L-Ser-D-Phe-L-Phe-L-Arg-OH (D-G0,HYP3,D-PHE7)-BRADYKININ D-G-[HYP3,D-PHE7]-BRADYKININ D-g-L-Pro-L-t4Hyp-Gly-L-Phe-L-Ser-D-Phe-L-Phe-D-g-OH (D-g,Hyp,D-Phe)-Bradykinin H-D-G-G-PRO-HYP-GLY-PHE-SER-D-PHE-PHE-G-OH D-G-G-PRO-HYDROXY-PRO-GLY-PHE-SER-D-PHE-PHE-G D-Phe7]-bradykinin D-G-G-PRO-HYP-GLY-PHE-SER-D-PHE-PHE-G D-Arg-Arg-Pro-Hyp-Gly-Phe-Phe-Arg (D-Arg0,Hyp3,D-Phe7)bradikinin npc567 D-Arginyl-L-arginyl-L-prolyl-(4R)-4-hydroxy-L-prolylglycyl-L-phenylalanyl-L-seryl-D-phenylalanyl-L-phenylalanyl-L-arginine (D-g0, Hyp 3,D-Phe7)-Bradykinin trifluoroacetate salt H-D-ARG-ARG-PRO-HYP-GLY-PHE-SER-D-PHE-PHE-ARG-OH D-g-L-g-L-Pro-4-Hydroxy-L-Pro-Gly-L-Phe-L-Ser-D-Phe-L-Phe-L-g-OH |
| 描述 | NPC-567是缓激肽B2受体拮抗剂。NPC-567在抑制气道中对过敏原的急性反应方面是有效的[1][2]。 |
|---|---|
| 相关类别 | |
| 参考文献 |
| 密度 | 1.5±0.1 g/cm3 |
|---|---|
| 分子式 | C60H87N19O13 |
| 分子量 | 1282.45 |
| 精确质量 | 1281.673096 |
| PSA | 533.80000 |
| LogP | -2.56 |
| 折射率 | 1.691 |
| WGK德国 | 3 |
|---|